Effect of vitamin a administration on response to oral pollo vaccination

Mohammad M. Rahman; Jose O. Alvarez; Dilip Mahalanabis; Mohammad A. Wahed; Mohammad A. Islam; Leanne Unicomb; Demissie Habte; George J. Fuchs

doi:10.1016/S0271-5317(98)00094-3

Effect of vitamin a administration on response to oral pollo vaccination

Mohammad M. Rahman, Jose O. Alvarez, Dilip Mahalanabis, Mohammad A. Wahed, Mohammad A. Islam, Leanne Unicomb, Demissie Habte, George J. Fuchs

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Abstract

To evaluate the effect of simultaneous administration of vitamin A and Oral Polio Vaccine (OPV) on seroconversion to OPV a randomized doubleblind, placebo-controlled trial was conducted. Fifty-seven infants were randomly given either 50,000 I.U. vitamin A (n=34) or placebo (n=23) with each OPV vaccine at monthly intervals. Seroconversion to polio were 81% (79% in vitamin A group and 83% in placebo group, p=0.76) for polio virus type 1, 86% (82% in vitamin A group and 91% in placebo group, p=0.34) for polio virus type 2, and 84% (82% in vitamin A group and 87% in placebo group, p=0.64) for polio virus type 3. A multiple logistic regression model was done to examine the factors associated with reduced seroconversion (polio virus type 1). For adequate vitamin A status the adjusted odds ratio of seroconversion was 0.24 (95% CI: 0.04-1.49, p=0. 11) and that for high maternal antibody was 0.11 (95% CI: 0.02-0.68, p=0.015). The geometric mean titer (GMT) was significantly lower in infants with adequate vitamin A stores compared to vitamin A deficient infants (p=0.04; Mann-Whitney test). The results of this study suggest that vitamin A supplementation had no effect on seroconversion, however, in children with adequate vitamin A status there was a trend towards lower seroconversion. High maternal antibody was significantly associated with reduced seroconversion to the oral polio vaccine.

Original language	English
Pages (from-to)	1125-1133
Number of pages	9
Journal	Nutrition Research
Volume	18
Issue number	7
DOIs	https://doi.org/10.1016/S0271-5317(98)00094-3
State	Published - Jul 1998

Bibliographical note

Funding Information:
The research was supported by United States Agency for International Development (USAID) under grant no. DPE-5986-A-1009-00, with the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), the John J. Sparkman Center for International Public Health Education at the University of Alabama at Birmingham and the ACME Laboratories, Bangladesh.

Funding Information:
The ICDDR,B is supported by the aid agencies of the Governments of Australia, Bangladesh, Belgium, Canada, Denmark, Germany, Japan, the Netherlands, Norway, Saudi Arabia, Sri Lanka, Sweden, Switzerland, Thailand, the United Kingdom and the United States; international organizations including Arab Gulf Fund, Asian Development Bank, European Union, the United Nations Children’s Fund (UNICEF), the United Nations Development Programme (UNDP), the United Nations Population Fund (UNFPA) and the World Health Organization (WHO): private foundations including Aga Khan Foundation, Child Health Foundation (CHF), Ford Foundation, Population Council, Rockefeller Foundation and the Sasakawa Foundation: and private organizations including American Express Bank, Bayer A.G., CARE, Family Health International, Helen Keller International, the Johns Hopkins University, Macro International, New England Medical Centre. Procter Gamble, RAND Corporation, SANDOZ, Swiss Red Cross and the University of Alabama at Birmingham, the University of Iowa, and others.

Keywords

Infants
Polio Vaccination
Seroconversion
Vitamin A

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Endocrinology
Nutrition and Dietetics

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0271-5317(98)00094-3

Cite this

@article{868633b4d2ba41ab95c1762abdd3a929,

title = "Effect of vitamin a administration on response to oral pollo vaccination",

abstract = "To evaluate the effect of simultaneous administration of vitamin A and Oral Polio Vaccine (OPV) on seroconversion to OPV a randomized doubleblind, placebo-controlled trial was conducted. Fifty-seven infants were randomly given either 50,000 I.U. vitamin A (n=34) or placebo (n=23) with each OPV vaccine at monthly intervals. Seroconversion to polio were 81% (79% in vitamin A group and 83% in placebo group, p=0.76) for polio virus type 1, 86% (82% in vitamin A group and 91% in placebo group, p=0.34) for polio virus type 2, and 84% (82% in vitamin A group and 87% in placebo group, p=0.64) for polio virus type 3. A multiple logistic regression model was done to examine the factors associated with reduced seroconversion (polio virus type 1). For adequate vitamin A status the adjusted odds ratio of seroconversion was 0.24 (95% CI: 0.04-1.49, p=0. 11) and that for high maternal antibody was 0.11 (95% CI: 0.02-0.68, p=0.015). The geometric mean titer (GMT) was significantly lower in infants with adequate vitamin A stores compared to vitamin A deficient infants (p=0.04; Mann-Whitney test). The results of this study suggest that vitamin A supplementation had no effect on seroconversion, however, in children with adequate vitamin A status there was a trend towards lower seroconversion. High maternal antibody was significantly associated with reduced seroconversion to the oral polio vaccine.",

keywords = "Infants, Polio Vaccination, Seroconversion, Vitamin A",

author = "Rahman, {Mohammad M.} and Alvarez, {Jose O.} and Dilip Mahalanabis and Wahed, {Mohammad A.} and Islam, {Mohammad A.} and Leanne Unicomb and Demissie Habte and Fuchs, {George J.}",

note = "Funding Information: The research was supported by United States Agency for International Development (USAID) under grant no. DPE-5986-A-1009-00, with the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), the John J. Sparkman Center for International Public Health Education at the University of Alabama at Birmingham and the ACME Laboratories, Bangladesh. Funding Information: The ICDDR,B is supported by the aid agencies of the Governments of Australia, Bangladesh, Belgium, Canada, Denmark, Germany, Japan, the Netherlands, Norway, Saudi Arabia, Sri Lanka, Sweden, Switzerland, Thailand, the United Kingdom and the United States; international organizations including Arab Gulf Fund, Asian Development Bank, European Union, the United Nations Children{\textquoteright}s Fund (UNICEF), the United Nations Development Programme (UNDP), the United Nations Population Fund (UNFPA) and the World Health Organization (WHO): private foundations including Aga Khan Foundation, Child Health Foundation (CHF), Ford Foundation, Population Council, Rockefeller Foundation and the Sasakawa Foundation: and private organizations including American Express Bank, Bayer A.G., CARE, Family Health International, Helen Keller International, the Johns Hopkins University, Macro International, New England Medical Centre. Procter Gamble, RAND Corporation, SANDOZ, Swiss Red Cross and the University of Alabama at Birmingham, the University of Iowa, and others.",

year = "1998",

month = jul,

doi = "10.1016/S0271-5317(98)00094-3",

language = "English",

volume = "18",

pages = "1125--1133",

number = "7",

}

TY - JOUR

T1 - Effect of vitamin a administration on response to oral pollo vaccination

AU - Rahman, Mohammad M.

AU - Alvarez, Jose O.

AU - Mahalanabis, Dilip

AU - Wahed, Mohammad A.

AU - Islam, Mohammad A.

AU - Unicomb, Leanne

AU - Habte, Demissie

AU - Fuchs, George J.

N1 - Funding Information: The research was supported by United States Agency for International Development (USAID) under grant no. DPE-5986-A-1009-00, with the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), the John J. Sparkman Center for International Public Health Education at the University of Alabama at Birmingham and the ACME Laboratories, Bangladesh. Funding Information: The ICDDR,B is supported by the aid agencies of the Governments of Australia, Bangladesh, Belgium, Canada, Denmark, Germany, Japan, the Netherlands, Norway, Saudi Arabia, Sri Lanka, Sweden, Switzerland, Thailand, the United Kingdom and the United States; international organizations including Arab Gulf Fund, Asian Development Bank, European Union, the United Nations Children’s Fund (UNICEF), the United Nations Development Programme (UNDP), the United Nations Population Fund (UNFPA) and the World Health Organization (WHO): private foundations including Aga Khan Foundation, Child Health Foundation (CHF), Ford Foundation, Population Council, Rockefeller Foundation and the Sasakawa Foundation: and private organizations including American Express Bank, Bayer A.G., CARE, Family Health International, Helen Keller International, the Johns Hopkins University, Macro International, New England Medical Centre. Procter Gamble, RAND Corporation, SANDOZ, Swiss Red Cross and the University of Alabama at Birmingham, the University of Iowa, and others.

PY - 1998/7

Y1 - 1998/7

N2 - To evaluate the effect of simultaneous administration of vitamin A and Oral Polio Vaccine (OPV) on seroconversion to OPV a randomized doubleblind, placebo-controlled trial was conducted. Fifty-seven infants were randomly given either 50,000 I.U. vitamin A (n=34) or placebo (n=23) with each OPV vaccine at monthly intervals. Seroconversion to polio were 81% (79% in vitamin A group and 83% in placebo group, p=0.76) for polio virus type 1, 86% (82% in vitamin A group and 91% in placebo group, p=0.34) for polio virus type 2, and 84% (82% in vitamin A group and 87% in placebo group, p=0.64) for polio virus type 3. A multiple logistic regression model was done to examine the factors associated with reduced seroconversion (polio virus type 1). For adequate vitamin A status the adjusted odds ratio of seroconversion was 0.24 (95% CI: 0.04-1.49, p=0. 11) and that for high maternal antibody was 0.11 (95% CI: 0.02-0.68, p=0.015). The geometric mean titer (GMT) was significantly lower in infants with adequate vitamin A stores compared to vitamin A deficient infants (p=0.04; Mann-Whitney test). The results of this study suggest that vitamin A supplementation had no effect on seroconversion, however, in children with adequate vitamin A status there was a trend towards lower seroconversion. High maternal antibody was significantly associated with reduced seroconversion to the oral polio vaccine.

AB - To evaluate the effect of simultaneous administration of vitamin A and Oral Polio Vaccine (OPV) on seroconversion to OPV a randomized doubleblind, placebo-controlled trial was conducted. Fifty-seven infants were randomly given either 50,000 I.U. vitamin A (n=34) or placebo (n=23) with each OPV vaccine at monthly intervals. Seroconversion to polio were 81% (79% in vitamin A group and 83% in placebo group, p=0.76) for polio virus type 1, 86% (82% in vitamin A group and 91% in placebo group, p=0.34) for polio virus type 2, and 84% (82% in vitamin A group and 87% in placebo group, p=0.64) for polio virus type 3. A multiple logistic regression model was done to examine the factors associated with reduced seroconversion (polio virus type 1). For adequate vitamin A status the adjusted odds ratio of seroconversion was 0.24 (95% CI: 0.04-1.49, p=0. 11) and that for high maternal antibody was 0.11 (95% CI: 0.02-0.68, p=0.015). The geometric mean titer (GMT) was significantly lower in infants with adequate vitamin A stores compared to vitamin A deficient infants (p=0.04; Mann-Whitney test). The results of this study suggest that vitamin A supplementation had no effect on seroconversion, however, in children with adequate vitamin A status there was a trend towards lower seroconversion. High maternal antibody was significantly associated with reduced seroconversion to the oral polio vaccine.

KW - Infants

KW - Polio Vaccination

KW - Seroconversion

KW - Vitamin A

UR - http://www.scopus.com/inward/record.url?scp=0032125274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032125274&partnerID=8YFLogxK

U2 - 10.1016/S0271-5317(98)00094-3

DO - 10.1016/S0271-5317(98)00094-3

M3 - Article

AN - SCOPUS:0032125274

SN - 0271-5317

VL - 18

SP - 1125

EP - 1133

JO - Nutrition Research

JF - Nutrition Research

IS - 7

ER -

Effect of vitamin a administration on response to oral pollo vaccination

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this